Atlas Trials

A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)

Clinical trial NCT07640217 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07640217
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adult Participants With Elevated Lipoprotein(a)
Start date
2026-07-30
Primary completion
2028-03-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.